AtriCure ATRC Europe — Revenue from Contract with Customer, Excluding Assessed Tax
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AtriCure in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about AtriCure's europe — revenue from contract with customer, excluding assessed tax.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AtriCure's europe — revenue from contract with customer, excluding assessed tax?
- AtriCure (ATRC) reported europe — revenue from contract with customer, excluding assessed tax of $16.07M in Q1 2026.
- How has AtriCure's europe — revenue from contract with customer, excluding assessed tax changed year-over-year?
- AtriCure's europe — revenue from contract with customer, excluding assessed tax increased by 13.2% year-over-year, from $14.2M to $16.07M.
- What is the long-term trend for AtriCure's europe — revenue from contract with customer, excluding assessed tax?
- Over 4 years (2021 to 2025), AtriCure's europe — revenue from contract with customer, excluding assessed tax has grown at a 21.8% compound annual growth rate (CAGR), from $27.93M to $61.49M.
- What does europe — revenue from contract with customer, excluding assessed tax mean?
- This metric measures the total net sales generated from the sale of medical devices and therapies to customers within the European market, excluding any collected sales or value-added taxes. It serves as a primary indicator of regional market penetration, product adoption rates, and the effectiveness of the local direct sales force. Tracking this figure allows for the evaluation of geographic growth trends and the company's competitive positioning in international healthcare markets.